(PharmaNewsWire.Com, December 21, 2017 ) The Europe Ultrasound Devices Market has been estimated at USD 1.90 Billion in 2016 and is projected to reach USD 2.35 Billion by 2021, at a CAGR of 4.4% during the forecast period from 2016 to 2021. Ultrasound is safe, noninvasive, and does not use ionizing radiation. Ultrasound imaging uses sound waves to produce pictures of the inside of the body. It is used to help diagnose the causes of pain, swelling and infection in the body’s internal organs and to examine a baby in pregnant women and the brain and hips in infants.
The factors such as rise in public & private investments and grants & funds for the development of more advanced ultrasound devices as well as to create awareness about the advantages offered by these devices are driving the market growth in Europe. Also, increase in number of ultrasound diagnostic imaging procedures, demand for minimal invasive therapies, and rise in awareness for early disease diagnosis are also driving the market growth. Stringent regulations for the approval of ultrasound device is regulating the growth of market.
Europe market for Ultrasound devices is segmented based on Technology, Device Display, Portability, and Application. By Technology, the market is segmented as Diagnostic Ultrasound (2D Ultrasound, 3D & 4D Ultrasound, Doppler Ultrasound) and Therapeutic Ultrasound (High-intensity Focused Ultrasound, Extracorporeal Shockwave Lithotripsy). By Device Display, the market is segmented as Color Ultrasound Devices and Black and White Ultrasound Devices. By Portability, the market is segmented as Trolley/Cart-based Ultrasound Devices and Compact/Handheld Ultrasound Devices. By Application, the market is segmented as Radiology/General Imaging, Cardiology, Obstetrics/Gynecology, Vascular, Urology and Other Applications (Includes Breast Imaging, Hepatology, Anesthesiology, and Emergency Care). The trolley/cart-based ultrasound devices segment is expected to account for the largest share of the Europe ultrasound market in 2015; whereas, the compact/handheld ultrasound devices segment is expected to grow at the highest CAGR during the forecast period. Cardiology application is expected to be the fastest growing segment during forecast period owing to rising incidence of cardiac diseases across the globe.
Geographically, Europe market for Ultrasound devices is segmented into U.K., France, Germany, Spain and Italy. Increasing market penetration of therapeutic ultrasound, and growing emphasis on minimally invasive procedures (including diagnostic and therapeutic ultrasound) is attracting the companies in this region, due to which they are able to contribute a maximum share to the global market.
General Electric Company (U.S.), Koninklijke Philips N.V. (Netherlands), Toshiba Corporation (Japan), Siemens AG (Germany), Hitachi Ltd. (Japan), Samsung Electronics Co., Ltd. (South Korea), FUJIFILM Holdings Corporation (Japan), Esaote S.p.A. (Italy), Mindray Medical International Ltd. (China), and Analogic Corporation (U.S.) are some of the key players in the Europe ultrasound market.
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
